Silver Book Fact

Greater use of clot-busting drug t-PA in ischemic
stroke patients could save the health care system
over $100 million a year.

New Stroke Treatment Likely to Decrease Health Care Costs and Increase Quality of Life. http://www.ninds.nih.gov/news_and_events/press_releases/pressrelease_stroke_treatment_042298.htm. Published 21-Apr-1998

Reference

Title
New Stroke Treatment Likely to Decrease Health Care Costs and Increase Quality of Life
Publication Date
Published 21-Apr-1998
Authors
National Institutes of Health, National Institute of Neurological Disorders and Stroke
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Medicines in Development for Heart Disease and Stroke, 2008  
  • About 70% of the survival improvement in heart attack mortality resulted from changes in technology.  
  • The rate of hospitalization from heart failure before and after transcatheter mitral valve repair (TMVR) decreases 73% (per patient year) in patients at prohibitive surgical risk.
     
  • A recent data analysis of more than 2,700 stroke patients from the U.S. and Europe confirmed tPA’s effectiveness, which could save the U.S. nearly $50 million a year.  
  • Undertreatment of patients with sSAS
    AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.